accountThe biggest drag on blue chips was Pfizer (PFE, Fortune 500), which reported earnings per share that beat by just a penny. The drugmaker reaffirmed its outlook, but investors were hoping for more. Shares fell 2.8%. Financial...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Stocks struggle as oil prices decline
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account